The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Cyclodextrin Drug Carrier Systems
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVArticleCyclodextrin Drug Carrier SystemsKaneto Uekama, Fumitoshi Hirayama, and Tetsumi IrieView Author Information Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1, Oe-honmachi, Kumamoto 862-0973, Japan Cite this: Chem. Rev. 1998, 98, 5, 2045–2076Publication Date (Web):June 9, 1998Publication History Received16 October 1997Revised5 January 1998Published online9 June 1998Published inissue 30 July 1998https://doi.org/10.1021/cr970025pCopyright © 1998 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views13329Altmetric-Citations1726LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (324 KB) Get e-AlertsSUBJECTS:Absorption,Macrocyclic compounds,Oligosaccharides,Peptides and proteins,Pharmaceuticals Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Comprehensive supramolecular chemistry
(1997) · Choice Reviews Online · doi:10.5860/choice.34-5097 · Cited by 6,476
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, T., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,176
The Stability of Cyclodextrin Complexes in Solution
Connors, K. A. (1997) · Chemical Reviews · doi:10.1021/cr960371r · Cited by 2,175
Gautier, J. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90025-i · Cited by 2,165
Cyclodextrin Inclusion Compounds in Research and Industry
Saenger, W. (1980) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198003441 · Cited by 1,943
Bender, M. L., & Komiyama, M. (1978) · Reactivity and Structure Concepts in Organic Chemistry · doi:10.1007/978-3-642-66842-5 · Cited by 1,893
Szejtli, J. (1988) · Topics in Inclusion Science · doi:10.1007/978-94-015-7797-7 · Cited by 1,759
Cyclodextrins and their inclusion complexes
Smolková-Keulemansová, E. (1982) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)88372-2 · Cited by 1,252
Higuchi, T. (1965) · Cited by 1,143
Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation
Irie, T., & Uekama, K. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960213f · Cited by 924
Self-citationCellular Cholesterol Efflux Mediated by Cyclodextrins
Kilsdonk, E. P. C., Yancey, P. G., Stoudt, G. W., Bangerter, F. W., Johnson, W. J., Phillips, M. C., & Rothblat, G. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17250 · Cited by 890
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
Rajewski, R. A., & Stella, V. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960075u · Cited by 824
Heparin Structure and Interactions with Basic Fibroblast Growth Factor
Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., & Rees, D. C. (1996) · Science · doi:10.1126/science.271.5252.1116 · Cited by 798
Cyclodextrins: Their Future in Drug Formulation and Delivery
Stella, V. J., & Rajewski, R. A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012136608249 · Cited by 697
Differential effects of α‐, β‐ and γ‐cyclodextrins on human erythrocytes
OHTANI, Y., IRIE, T., UEKAMA, K., FUKUNAGA, K., & PITHA, J. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb15171.x · Cited by 613
Self-citationSugiuchi, H., Uji, Y., Okabe, H., Irie, T., Uekama, K., Kayahara, N., & Miyauchi, K. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.5.717 · Cited by 459
Self-citationTo Oxford University Press, New York
Housman, A. E. (2007) · The Letters of A. E. Housman · doi:10.1093/oseo/instance.00293401 · Cited by 336
Hydroxypropyl-β-cyclodextrin: preparation and characterization; effects on solubility of drugs
Pitha, J., Milecki, J., Fales, H., Pannell, L., & Uekama, K. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90201-2 · Cited by 304
Self-citationThe Blood-brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System
Begley, D. J. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb07112.x · Cited by 291
Control of Angiogenesis with Synthetic Heparin Substitutes
Folkman, J., Weisz, P. B., Joullié, M. M., Li, W. W., & Ewing, W. R. (1989) · Science · doi:10.1126/science.2467380 · Cited by 289
Discovery of a New Mechanism and Development of Angiogenic Therapy That Accelerates Healing
FOLKMAN, J., SZABO, S., STOVROFF, M., MCNEIL, P., LI, W., & SHING, Y. (1991) · Annals of Surgery · doi:10.1097/00000658-199110000-00006 · Cited by 280
Artificial Chaperones: Protein Refolding via Sequential Use of Detergent and Cyclodextrin
Rozema, D., & Gellman, S. H. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00113a036 · Cited by 237
Amorphous Water-Soluble Derivatives of Cyclodextrins: Nontoxic Dissolution Enhancing Excipients
Pitha, J., & Pitha, J. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740916 · Cited by 212
Rozema, D., & Gellman, S. H. (1996) · Biochemistry · doi:10.1021/bi961638j · Cited by 207
Cyclodextrin nephrosis in the rat.
Frank, D. W., Gray, J. E., & Weaver, R. N. (1976) · PubMed · Cited by 204
Artificial Chaperone-assisted Refolding of Carbonic Anhydrase B
Rozema, D., & Gellman, S. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3478 · Cited by 199
Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.
IRIE, T., OTAGIRI, M., SUNADA, M., UEKAMA, K., OHTANI, Y., YAMADA, Y., & SUGIYAMA, Y. (1982) · Journal of Pharmacobio-Dynamics · doi:10.1248/bpb1978.5.741 · Cited by 188
Self-citationSorimachi, K., Gal-Coëffet, M.-F. L., Williamson, G., Archer, D. B., & Williamson, M. P. (1997) · Structure · doi:10.1016/s0969-2126(97)00220-7 · Cited by 184
Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells.
Atger, V. M., de la Llera Moya, M., Stoudt, G. W., Rodrigueza, W. V., Phillips, M. C., & Rothblat, G. H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119223 · Cited by 176
Sharff, A. J., Rodseth, L. E., & Quiocho, F. A. (1993) · Biochemistry · doi:10.1021/bi00091a004 · Cited by 174
Use of 2-Hydroxypropyl-β-cyclodextrin as a Solubilizing and Stabilizing Excipient for Protein Drugs
Brewster, M. E., Hora, M., Simpkins, J. W., & Bodor, N. S. (1991) · Pharmaceutical Research · doi:10.1023/a:1015870521744 · Cited by 156
The Effect of Parenterally Administered Cyclodextrins on Cholesterol Levels in the Rat
Frijlink, H. W., Eissens, A. C., Hefting, N. R., Poelstra, K., Lerk, C. F., & Meijer, D. K. F. (1991) · Pharmaceutical Research · doi:10.1023/a:1015861719134 · Cited by 152
Absorption Enhancing Effect of Cyclodextrins on Intranasally Administered Insulin in Rats
Merkus, F. W. H. M., Verhoef, J. C., Romeijn, S. G., & Schipper, N. G. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015896405389 · Cited by 146
Cyclodextrins as Nasal Absorption Promoters of Insulin: Mechanistic Evaluations
Shao, Z., Krishnamoorthy, R., & Mitra, A. K. (1992) · Pharmaceutical Research · doi:10.1023/a:1015847604654 · Cited by 136
Irie, T., Fukunaga, K., & Pitha, J. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810609 · Cited by 135
Self-citationHydrophilic Cyclodextrin Derivatives Enable Effective Oral Administration of Steroidal Hormones
Pitha, J., Harman, S. M., & Michel, M. E. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750213 · Cited by 132
Charman, S. A., Mason, K. L., & Charman, W. N. (1993) · Pharmaceutical Research · doi:10.1023/a:1018994102218 · Cited by 124
β‐Cyclodextrin interacts with the Alzheimer amyloid β‐A4 peptide
Camilleri, P., Haskins, N. J., & Hewlett, D. R. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80467-2 · Cited by 117
Effect of Cyclodextrins on Topical Drug Delivery to the Eye
Loftsson, Þ., & Stefánsson, E. (1997) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049709148496 · Cited by 113
Oral colon-specific drug delivery
Pavelić, Ž., Nigović, B., Konosić, P., & Bećirević‐Laćan, M. (2006) · Cited by 110
Severe hypervitaminosis A in siblings: Evidence of variable tolerance to retinol intake
Carpenter, T. O., Pettifor, J. M., Russell, R. M., Pitha, J., Mobarhan, S. M., Ossip, M. S., Wainer, S., & Anast, C. S. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80109-9 · Cited by 107
Adjei, A. L., Sundberg, D. P., Miller, J., & Chun, A. (1992) · Pharmaceutical Research · doi:10.1023/a:1018997625726 · Cited by 103
Marttin, E., Verhoef, J. C., Romeijn, S. G., & Merkus, F. W. H. M. (1995) · Pharmaceutical Research · doi:10.1023/a:1016207809199 · Cited by 101
Cyclodextrin complexation of NSAIDSs: physicochemical characteristics
Loftsson, Þ., Ólafsdóttir, B. J., Friđriksdóttir, H., & Jónsdóttir, S. (1993) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(93)90023-4 · Cited by 101
Sugiuchi, H., Irie, T., Uji, Y., Ueno, T., Chaen, T., Uekama, K., & Okabe, H. (1998) · PubMed · Cited by 100
Self-citationInclusion complexation of tolbutamide with β-cyclodextrin and hydroxypropyl-β-cyclodextrin
Veiga, F., Teixeira-Dias, J. J. C., Kedzierewicz, F., Sousa, A. F., & Maincent, P. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04243-1 · Cited by 100
Sugiuchi, H., Irie, T., Uji, Y., Ueno, T., Chaen, T., Uekama, K., & Okabe, H. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.3.522 · Cited by 97
Self-citationJärvinen, T., Järvinen, K., Schwarting, N., & Stella, V. J. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840306 · Cited by 96
Schipper, N. G. M., Romeijn, S. G., Verhoef, J. C., & Merkus, F. W. H. M. (1993) · Pharmaceutical Research · doi:10.1023/a:1018999414088 · Cited by 91
Improvement of the Oral Bioavailability of Digitalis Glycosides by CyclodextrinComplexation
Uekama, K., FUJINAGA, T., Hirayama, F., Otagiri, M., Yamasaki, M., Seo, H., Hashimoto, T., & Tsuruoka, M. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721125 · Cited by 90
Self-citationUekama, K., Minami, K., & Hirayama, F. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970130r · Cited by 90
Self-citationSuppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837)
Al‐Nakib, W., Higgins, P. G., Barrow, G. I., Tyrrell, D. A. J., Andries, K., Bussche, G. V., Taylor, N., & Janssen, P. A. J. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.4.522 · Cited by 87
Ferrell, J. E., Lee, K., & Huestis, W. H. (1985) · Biochemistry · doi:10.1021/bi00333a007 · Cited by 87
Enhancing effects of cyclodextrins on nasal absorption of insulin in rats
Irie, T., Wakamatsu, K., Arima, H., Aritomi, H., & Uekama, K. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90053-5 · Cited by 84
Self-citationBentley, M. V. L. B., Lopez, R. F. V., Wilson, S., & Collett, J. H. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06813.x · Cited by 82
Pitha, J., & Hoshino, T. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90281-6 · Cited by 80
Usayapant, A., Karara, A. H., & Narurkar, M. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015838215268 · Cited by 77
Enzymic degradation of .alpha.- and .beta.-cyclodextrins by Bacteroides of the human colon
Antenucci, R. N., & Palmer, J. K. (1984) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00126a025 · Cited by 76
Matsubara, K., Abe, K., Irie, T., & Uekama, K. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600841108 · Cited by 74
Self-citationStuenkel, C. A., Dudley, R. E., & Yen, S. S. C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-5-1054 · Cited by 73
Nasal Absorption Enhancement of 17β-Estradiol by Dimethyl-β-Cyclodextrin in Rabbits and Rats
Hermens, W. A. J. J., Deurloo, M. J. M., Romeyn, S. G., Verhoef, J. C., & Merkus, F. W. H. M. (1990) · Pharmaceutical Research · doi:10.1023/a:1015816716544 · Cited by 73
Sigurðoardóttir, A. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04095-1 · Cited by 71
Lyophilized Formulations of Recombinant Tumor Necrosis Factor
Hora, M., Rana, R. K., & Smith, F. W. (1992) · Pharmaceutical Research · doi:10.1023/a:1018919508463 · Cited by 66
Ressing, M. E., Jiskoot, W., Talsma, H., van Ingen, C. W., Beuvery, E. C., & Crommelin, D. J. A. (1992) · Pharmaceutical Research · doi:10.1023/a:1018905927544 · Cited by 66
Modulation of Human Fibroblast Activity by Selected Angiogenesis Inhibitors
Wong, J., Wang, N., Miller, J. W., & Schuman, J. S. (1994) · Experimental Eye Research · doi:10.1006/exer.1994.1037 · Cited by 66
Kinetic difference between hydrolyses of γ-cyclodextrin by human salivary and pancreatic α-amylases
MARSHALL, J. J., & Miwa, I. (1981) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(81)90093-0 · Cited by 64
Effect of cyclodextrins and undigested starch on the loss of chenodeoxycholate in the faeces
Abadie, C., Hug, M. N., Kübli, C., & Gains, N. (1994) · Biochemical Journal · doi:10.1042/bj2990725 · Cited by 63
Synthesis of a new molecular carrier: N-(Leu-enkephalin)yl 6-amido-6-deoxy-cyclomaltoheptaose
Djedaïni‐Pilard, F., Désalos, J., & Perly, B. (1993) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)60440-9 · Cited by 61
Reer, O., Bock, T. K., & Müller, B. W. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830928 · Cited by 60
Tokihiro, K., Irie, T., & Uekama, K. (1997) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.45.525 · Cited by 58
Self-citationSchipper, N. G. M., Hermens, W. A. J. J., Romeyn, S. G., Verhoef, J., & Merkus, F. W. H. M. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90179-8 · Cited by 58
The utilization of Schardinger dextrins by the rat
Andersen, G. H., Robbins, F. M., Domingues, F. J., Moores, R. G., & Long, C. L. (1963) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(63)90048-6 · Cited by 57
Hirayama, F., Minami, K., & Uekama, K. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb05871.x · Cited by 56
Self-citationMerkus, F. W. H. M., Schipper, N. G. M., & Verhoef, J. C. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01357-0 · Cited by 55
Jarho, P., Urtti, A. O., Pate, D. W., Suhonen, P., & Järvinen, T. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04522-x · Cited by 55
Irie, T., Fukunaga, K., Garwood, M. K., Carpenter, T. O., Pitha, J. V., Pitha, J., Pitha, J., & Pitha, J. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810610 · Cited by 53
Self-citationTaylor, G. T., Weiss, J. M., & Pitha, J. (1989) · Pharmaceutical Research · doi:10.1023/a:1015922019038 · Cited by 51
Tokumura, T., Nanbas, M., Tsushima, Y., Tatsuishi, K., Kayano, M., Machida, Y., & Nagai, T. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750415 · Cited by 51
Uekama, K., Adachi, H., Irie, T., Yano, T., Saita, M., & Noda, K. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb03574.x · Cited by 49
Self-citation2-hydroxypropyl-β-cyclodextrin in topical carbonic anhydrase inhibitor formulations
Loftsson, Þ., Friđriksdóttir, H., Thórisdóttir, S., Stefánsson, E., Sigurðardóttir, A. M., Gudmundsson, Ó. S., & Sigthórsson, T. (1994) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(94)90001-9 · Cited by 49
der Auwera, B. J. R. V., Schuit, F. C., Lyaruu, I., Falorni, A., Svanholm, S., Vandewalle, C. L., & Gorus, F. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.9.2567 · Cited by 49
Soliman, O. A.-E., Kimura, K., Hirayama, F., et al. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04862-4 · Cited by 48
Self-citationSlow-Release Characteristics of Diltiazem from Ethylated β-Cyclodextrin Complexes
Horiuchi, Y., Hirayama, F., & Uekama, K. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790211 · Cited by 48
Self-citationIntranasal estradiol administration to oophorectomized women
Hermens, W. A. J. J., Belder, C. W. J., Merkus, J. M. W. M., Hooymans, P. M., Verhoef, J., & Merkus, F. W. H. M. (1991) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(91)90042-j · Cited by 48
Reduction in the ulcerogenicity of naproxen by complexation with β-cyclodextrin
Otero-Espinar, F. J., Anguiano-Igea, S., Blanco-Méndez, J., & Jato, J. L. V. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90161-g · Cited by 47
YOSHIDA, A., Yamamoto, M., Takahiro, I. T. O. H., et al. (1990) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.38.176 · Cited by 47
Methylated ?-cyclodextrins are able to improve the nasal absorption of salmon calcitonin
Schipper, N. G. M., Verhoef, J. C., Romeijn, S. G., & Merkus, F. W. H. M. (1995) · Calcified Tissue International · doi:10.1007/bf00318047 · Cited by 46
Zia, V., Rajewski, R. A., Bornancini, E. R. N., Luna, E. A., & Stella, V. J. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960236u · Cited by 44
Lin, S.-Z., Wouessidjewe, D., Poelman, M.-C., et al. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90276-3 · Cited by 43
Wang, Z., Horikawa, T., Hirayama, F., & Uekama, K. (1993) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1993.tb05631.x · Cited by 43
Self-citationEstes, K. S., Brewster, M. E., Webb, A. I., & Bodor, N. S. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90014-u · Cited by 42
The effect of nasal drug formulations on ciliary beating in vitro
Romeijn, S. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04460-2 · Cited by 42
Uekama, K., Horikawa, T., Yamanaka, M., & Hirayama, F. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03889.x · Cited by 41
Self-citationUekama, K., Arima, H., Irie, T., et al. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06393.x · Cited by 40
Self-citationUtilization of Diethyl-β-Cyclodextin as a Sustained-Release Carrier for Isosorbide Dinitrate
Hirayama, F., Hirashima, N., Abe, K., Uekama, K., Ijitsu, T., & Ueno, M. (1988) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600770310 · Cited by 39
Self-citationHydroxypropyl-β-cyclodextrin increases aqueous solubility and stability of anandamide
Jarho, P., Urtti, A. O., Järvinen, K., Pate, D. W., & Järvinen, T. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00024-0 · Cited by 38
Suzuki, M., & Sato, A. (1985) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.31.209 · Cited by 38
Williams, K. J., Vallabhajosula, S., Rahman, I., et al. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.1.242 · Cited by 37
Amidouche, D., Montassier, P., Poelman, M.-C., & Duchêne, D. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00090-5 · Cited by 36
MASAHIKO, K., FUMITOSHI, H., & KANETO, U. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90114-1 · Cited by 35
Marttin, E., Verhoef, J. C., Romeijn, S. G., Zwart, P., & Merkus, F. W. H. M. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04632-7 · Cited by 35
Biochemical Studies of Metalloendoprotease Activity in the Spermatozoa of Three Mammalian Species
Gottlieb, W., & Meizel, S. (1987) · Journal of Andrology · doi:10.1002/j.1939-4640.1987.tb02411.x · Cited by 29
Uekama, K., Kondo, T., Nakamura, K., Irie, T., Arakawa, K., Shibuya, M., & Tanaka, J. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840106 · Cited by 28
Self-citationFukunaga, K., Hijikata, S., Ishimura, K., et al. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03771.x · Cited by 25
γ-Cyclodextrin: Testosterone Complex Suitable for Sublingual Administration
Pitha, J., Anaissie, E. J., & Uekama, K. (1987) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600761007 · Cited by 25
Self-citationSakr, F. M. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04385-3 · Cited by 24
Anand, R., Nayyar, S., Pitha, J., & Merril, C. R. (1990) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029000100107 · Cited by 23
Gottlieb, D., & Shaw, P. D. (1967) · Springer eBooks · doi:10.1007/978-3-642-46051-7 · Cited by 22
Santucci, L., Fiorucci, S., Chiucchi�, S., et al. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01308075 · Cited by 21
Formulation and clinical evaluation of a hydrocortisone solution for the treatment of oral disease
Kristmundsdottir, T., Loftsson, Þ., & Holbrook, W. P. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04565-6 · Cited by 21
Martini, A. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04229-6 · Cited by 18
Yoshimura, Y., Kitahata, S., & Okada, S. (1987) · Carbohydrate Research · doi:10.1016/0008-6215(87)80031-9 · Cited by 16
Matsubara, K., Irie, T., & Uekama, K. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)00030-1 · Cited by 14
Self-citationMASUDA, K., Ito, A., IKARI, T., TERASHIMA, A., & Matsuyama, T. (1984) · YAKUGAKU ZASSHI · doi:10.1248/yakushi1947.104.10_1075 · Cited by 11
Matsubara, K., 栗木武男, Arima, H., 浩太郎, 若., Irie, T., & Uekama, K. (1990) · Drug Delivery System · doi:10.2745/dds.5.95 · Cited by 8
Self-citation
Cited by
Drug Solubility: Importance and Enhancement Techniques
Savjani, K. T., Gajjar, A. K., & Savjani, J. K. (2012) · ISRN Pharmaceutics · doi:10.5402/2012/195727 · Cited by 2,004
Cyclodextrin-based pharmaceutics: past, present and future
Davis, M. E., & Brewster, M. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1576 · Cited by 1,996
Review: A History of Cyclodextrins
Crini, G. (2014) · Chemical Reviews · doi:10.1021/cr500081p · Cited by 1,906
Cyclodextrins as pharmaceutical solubilizers
Brewster, M. E., & Loftsson, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.012 · Cited by 1,882
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Metadata
- Authors
- Uekama, K., Hirayama, F., & Irie, T.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 1998-06-09
- Volume
- 98
- Issue
- 5
- Pages
- 2045-2076
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W1996481160
- Cited by
- 2,145
- References
- 116
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.